QUADRANT CAPITAL GROUP LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45,200
+54.8%
1,659
+26.4%
0.01%
+66.7%
Q2 2023$29,192
+11.5%
1,312
+8.5%
0.00%0.0%
Q1 2023$26,187
-10.3%
1,209
-15.9%
0.00%0.0%
Q4 2022$29,206
-27.0%
1,438
-8.5%
0.00%
-40.0%
Q3 2022$40,000
+700.0%
1,571
+714.0%
0.01%
+400.0%
Q2 2022$5,000
-16.7%
193
-27.7%
0.00%0.0%
Q1 2022$6,000
+50.0%
267
+38.3%
0.00%
Q4 2021$4,000
-33.3%
193
-38.7%
0.00%
-100.0%
Q3 2021$6,000
+50.0%
315
+59.1%
0.00%0.0%
Q2 2021$4,000
-20.0%
198
-10.4%
0.00%0.0%
Q1 2021$5,0000.0%221
+14.5%
0.00%0.0%
Q4 2020$5,000
+66.7%
1930.0%0.00%0.0%
Q3 2020$3,0000.0%1930.0%0.00%0.0%
Q2 2020$3,000
-88.5%
193
-91.0%
0.00%
-75.0%
Q1 2020$26,000
+4.0%
2,139
+2.8%
0.00%
+33.3%
Q4 2019$25,000
-13.8%
2,0800.0%0.00%
-25.0%
Q3 2019$29,000
+26.1%
2,0800.0%0.00%0.0%
Q2 2019$23,000
+2200.0%
2,080
+2160.9%
0.00%
Q1 2019$1,0000.0%92
-37.4%
0.00%
Q4 2018$1,0000.0%147
+59.8%
0.00%
Q3 2018$1,0000.0%920.0%0.00%
Q2 2018$1,000
-66.7%
92
-61.2%
0.00%
-100.0%
Q1 2018$3,0000.0%237
+23.4%
0.00%0.0%
Q4 2017$3,0000.0%1920.0%0.00%0.0%
Q3 2017$3,000
+50.0%
1920.0%0.00%0.0%
Q2 2017$2,0000.0%1920.0%0.00%0.0%
Q1 2017$2,0001920.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders